| Recruitment status | No longer recruiting |
| Unique ID issued by UMIN | UMIN000019940 |
| Receipt No. | R000023027 |
| Scientific Title | Seizure Outcomes and Predictors of Recurrent Post-stroke Seizure:A prospective observational cohort study |
| Date of disclosure of the study information | 2015/11/29 |
| Last modified on | 2020/01/13 (Ver. 8) |
| Basic information | ||
| Public title | Seizure Outcomes and Predictors of Recurrent Post-stroke Seizure:A prospective observational cohort study | |
| Acronym | PROgnosis of Post Stroke Epilepsy (PROPOSE) study | |
| Scientific Title | Seizure Outcomes and Predictors of Recurrent Post-stroke Seizure:A prospective observational cohort study | |
| Scientific Title:Acronym | PROgnosis of Post Stroke Epilepsy (PROPOSE) study | |
| Region |
|
|
| Condition | |||
| Condition | Post stroke seizure | ||
| Classification by specialty |
|
||
| Classification by malignancy | Others | ||
| Genomic information | NO | ||
| Objectives | |
| Narrative objectives1 | To identify reliable predictors of recurrent seizure in patients with late seizures and to evaluate the outcome of different AED regimens for secondary prevention. |
| Basic objectives2 | Others |
| Basic objectives -Others | We compared baseline clinical characteristics and post-stroke treatment regimens between recurrent and non-recurrent PSS patients to identify factors predictive of recurrence. |
| Trial characteristics_1 | Confirmatory |
| Trial characteristics_2 | Explanatory |
| Developmental phase | Not applicable |
| Assessment | |
| Primary outcomes | recurrence of post stroke seizure |
| Key secondary outcomes | compliance of antiepileptic drugs |
| Base | |
| Study type | Observational |
| Study design | |
| Basic design | |
| Randomization | |
| Randomization unit | |
| Blinding | |
| Control | |
| Stratification | |
| Dynamic allocation | |
| Institution consideration | |
| Blocking | |
| Concealment | |
| Intervention | |
| No. of arms | |
| Purpose of intervention | |
| Type of intervention | |
| Interventions/Control_1 | |
| Interventions/Control_2 | |
| Interventions/Control_3 | |
| Interventions/Control_4 | |
| Interventions/Control_5 | |
| Interventions/Control_6 | |
| Interventions/Control_7 | |
| Interventions/Control_8 | |
| Interventions/Control_9 | |
| Interventions/Control_10 | |
| Eligibility | ||||
| Age-lower limit |
|
|||
| Age-upper limit |
|
|||
| Gender | Male and Female | |||
| Key inclusion criteria | patients diagnosed with seizure and selected patients with a history of preceding stroke. seizures occurring at least one weeks after stroke were defined as late seizures. | |||
| Key exclusion criteria | 1. acute symptomatic seizure
2. non poststroke seizure 3. patient who reject to be recruited |
|||
| Target sample size | 500 | |||
| Research contact person | |||||||
| Name of lead principal investigator |
|
||||||
| Organization | National Cerebral and Cardiovascular Center | ||||||
| Division name | Department of Stroke and Cerebrovascular Diseases | ||||||
| Zip code | 564-8565 | ||||||
| Address | 6-1 Kishibe-Shimmachi, Suita, Osaka, Japan | ||||||
| TEL | 06-6170-1070 | ||||||
| tanakat@hsp.ncvc.go.jp | |||||||
| Public contact | |||||||
| Name of contact person |
|
||||||
| Organization | Department of Stroke and Cerebrovascular Diseases | ||||||
| Division name | Department of Stroke and Cerebrovascular Diseases | ||||||
| Zip code | 564-8565 | ||||||
| Address | 6-1 Kishibe-Shimmachi, Suita, Osaka, Japan | ||||||
| TEL | 06-6170-1070 | ||||||
| Homepage URL | |||||||
| tanakat@hsp.ncvc.go.jp | |||||||
| Sponsor | |
| Institute | National Cerebral and Cardiovascular Center |
| Institute | |
| Department | |
| Funding Source | |
| Organization | National Cerebral and Cardiovascular Center |
| Organization | |
| Division | |
| Category of Funding Organization | Other |
| Nationality of Funding Organization | |
| Other related organizations | |
| Co-sponsor | |
| Name of secondary funder(s) | |
| IRB Contact (For public release) | |
| Organization | National Cerebral and Cardiovascular Center |
| Address | 6-1 Kishibe-Shimmachi, Suita, Osaka, Japan |
| Tel | 06-6170-1070 |
| tanakat@hsp.ncvc.go.jp | |
| Secondary IDs | |
| Secondary IDs | NO |
| Study ID_1 | |
| Org. issuing International ID_1 | |
| Study ID_2 | |
| Org. issuing International ID_2 | |
| IND to MHLW | |
| Institutions | |
| Institutions | ・京都大学,運動異常生理学講座
・神戸市立医療センター中央市民病院,神経内科 ・東京都健康長寿医療センター,神経内科 ・中村記念病院,神経内科 ・聖マリア病院 脳血管内科 ・トヨタ記念病院 神経内科 ・熊本済生会病院 神経内科 ・独立行政法人国立病院機構 岡山医療センター 神経内科 |
| Other administrative information | |||||||
| Date of disclosure of the study information |
|
||||||
| Related information | |
| URL releasing protocol | |
| Publication of results | Unpublished |
| Result | |
| URL related to results and publications | |
| Number of participants that the trial has enrolled | |
| Results | |
| Results date posted | |
| Results Delayed | |
| Results Delay Reason | |
| Date of the first journal publication of results | |
| Baseline Characteristics | |
| Participant flow | |
| Adverse events | |
| Outcome measures | |
| Plan to share IPD | |
| IPD sharing Plan description | |
| Progress | |||||||
| Recruitment status | No longer recruiting | ||||||
| Date of protocol fixation |
|
||||||
| Date of IRB |
|
||||||
| Anticipated trial start date |
|
||||||
| Last follow-up date |
|
||||||
| Date of closure to data entry | |||||||
| Date trial data considered complete | |||||||
| Date analysis concluded | |||||||
| Other | |
| Other related information | Study design:prospective observational cohort study
Study population: Patients with post stroke seizures admitted to our department between November 2014 and September 2018. Outcomes: Information regarding recurrent seizure was collected through inspection of inpatient and outpatient records or telephone inquiry with the patients themselves or relatives: the seizure recurrence, efficacy and modifications of AEDs and neurological status are recorded. The following demographic and clinical characteristics are collected from medical records: age, sex, previous stroke type, previous late seizures, traumatic brain injury, neurosurgical intervention, dementia, family history of epilepsy, smoking, drinking alcohol, and stroke risk factors. We also check blood test, MR image, SPECT, EEG. |
| Management information | |||||||
| Registered date |
|
||||||
| Last modified on |
|
||||||
| Link to view the page | |
| URL(English) | https://upload.umin.ac.jp/cgi-open-bin/ctr_e/ctr_view.cgi?recptno=R000023027 |